Myotonic dystrophy type 1 (DM1): A triplet repeat expansion disorder

Gene

Volumn 522, Issue 2, 2013, Pages 226-230

  Kumar, Ashok ^a   Agarwal, Sarita ^a   Agarwal, Divya ^a   Phadke, Shubha R ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

CTG repeat; DMPK gene; Genetics; Myotonic dystrophy type 1 (DM1); Triplet repeat disorder

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CALCIUM ANTAGONIST; CLOMIPRAMINE; DEXAMPHETAMINE; METHYLPHENIDATE; MODAFINIL; MYOTONIC DYSTROPHY PROTEIN KINASE; PHENYTOIN; PRASTERONE; PREDNISOLONE; PROCAINAMIDE; TAURINE;

3' UNTRANSLATED REGION; ALLELE; ANTISENSE THERAPY; CATARACT; CATARACT EXTRACTION; CHROMOSOME 19Q; CHROMOSOME 3Q; CLINICAL FEATURE; DISEASE SEVERITY; EXON; GENE MUTATION; GENETICS; HEART ARRHYTHMIA; HUMAN; HYPERSOMNIA; HYPOGONADISM; LETTER; MOLECULAR DIAGNOSIS; MUSCLE WEAKNESS; MYALGIA; MYOTONIA; MYOTONIC DYSTROPHY; NERVE BLOCK; NONHUMAN; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA METABOLISM; SLEEP DISORDERED BREATHING; TRIPLET PRIMED POLYMERASE CHAIN REACTION;

HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; MUSCLE RELAXATION; MUSCLE WEAKNESS; MYOTONIC DYSTROPHY; PROTEIN-SERINE-THREONINE KINASES; RNA; RNA-BINDING PROTEINS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 84878107830     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.03.059     Document Type: Letter

References (44)

1. Addis M., Serrenti M., Meloni C., Cau M., Melis M.A. Triplet-primed PCR is more sensitive than Southern blotting-long PCR for the diagnosis of myotonic dystrophy type1. Genet. Test. Mol. Biomarkers 2012, 16(12):1428-1431.
2. Botta A., et al. The CTG repeat expansion size correlates with the splicing defects observed in muscles from myotonic dystrophy type 1 patients. J. Med. Genet. 2008, 45(10):639-646.
3. Brook J.D., et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 1992, 68:799-808.
4. Chahine M., George A.L. Myotonic dystrophy kinase modulates skeletal muscle but not cardiac voltage-gated sodium channels. FEBS Lett. 1997, 412(3):621-624.
5. de Haro M., et al. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a drosophila model of myotonic dystrophy 1. Hum. Mol. Genet. 2006, 15:2138-2145.
6. Frisch R., et al. Effect of triplet repeat expansion on chromatin structure and expression of DMPK and neighboring genes, SIX5 and DMWD, in myotonic dystrophy. Mol. Genet. Metab. 2001, 74(1-2):281-291.
7. Furling D., et al. Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions. Gene Ther. 2003, 10:795-802.
8. Garrott H.M., Walland M.J., O'Day J. Recurrent posterior capsular opacification and capsulorhexis contracture after cataract surgery in myotonic dystrophy. Clin. Experiment. Ophthalmol. 2004, 32:653-655.
9. Goossens V., et al. Diagnostic efficiency, embryonic development and clinical outcome after the biopsy of one or two blastomeres for preimplantation genetic diagnosis. Hum. Reprod. 2008, 223:481-492.
10. Harley H.G., et al. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 1992, 355:545-546.
11. Harley H.G., et al. Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am. J. Hum. Genet. 1993, 52:1164-1174.
12. Harper P.S. Myotonic Dystrophy 1989, W.B. Saunders Co., Philadelphia PA. 2nd edn.
13. Harper P.S. Major problems in neurology. Myotonic Dystrophy 2001, 37. W.B. Saunders, Philadelphia. 3rd ed.
14. Ho T.H., Bundman D., Amstrong D.L., Cooper T.A. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. Hum. Mol. Genet. 2005, 14:1539-1547.
15. Howeler C.J., Busch H.F.M., Geraedts J.P.M., Neirmeijer M.F., Staal A. Anticipation in myotonic dystrophy: fact or fiction?. Brain 1989, 112:779-797.
16. Hunter A., et al. The correlation of age of onset with CTG trinucleotide repeat amplification in myotonic dystrophy. J. Med. Genet. 1992, 29:774-779.
17. Kanadia R.N., et al. A muscleblind knockout model for myotonic dystrophy. Science 2003, 302:1978-1980.
18. Karen Usdin The biological effects of simple tandem repeats: lessons from the repeat expansion diseases. Genome Res. 2008, 18:1011-1019.
19. Khajavi M., et al. "Mitotic drive" of expanded CTG repeats in myotonic dystrophy type (DM1). Hum. Mol. Genet. 2001, 10:855-863.
20. Klesert T.R., Otten A.D., Tapscott S.J. Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP. Nat. Genet. 1997, 16(4):402-406.
21. Klesert T.R., et al. Mice deficient in Six5 develop cataracts: implications for myotonic dystrophy. Nat. Genet. 2000, 25:105-109.
22. Lamusi B., Artero R. Molecular effects of the CTG repeats in mutant dystrophia myotonica protein kinase gene. Curr. Genomics 2008, 9:509-516.
23. Mahadevan M., et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science 1992, 255:1253-1255.
24. Mahadevan M.S., et al. Structure and genomic sequence of the myotonic dystrophy (DM kinase) gene. Hum. Mol. Genet. 1993, 2:299-304.
25. Mankodi A., et al. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum. Mol. Genet. 2001, 10:2165-2170.
26. Mathieu J., et al. 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology 1999, 52:1658-1662.
27. Miller J.W., et al. Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy. EMBO J. 2000, 19:4439-4448.
28. Musova Z., et al. Highly unstable sequence interruptions of the CTG repeat in the myotonic dystrophy gene. Am. J. Med. Genet. 2009, 149A:1365-1374.
29. Nakazora H., Kurihara T. The effect of dehydroepiandrosterone sulfate (DHEAS) on myotonia: intracellular studies. Intern. Med. 2005, 44:1247-1251.
30. Personius K.E., Nautiyal J., Reddy S. Myotonia and muscle contractile properties in mice with SIX5 deficiency. Muscle Nerve 2005, 31(4):503-505.
31. Redman J.B., Fenwick R.G., Fu Y.H., Pizzuti A., Caskey C.T. Relationship between parental trinucleotide GCT repeat length and severity of myotonic dystrophy in offspring. JAMA 1993, 269:1960-1965.
32. Ricker K., et al. Linkage of proximal myotonic myopathy to chromosome 3q. Neurology 1999, 52:170-171.
33. Schara U., Schoser B.G.H. Myotonic Dystrophies type 1 and 2 - a summary of current aspects. Semin. Pediatr. Neurol. 2006, 13:71-79.
34. Schoser B., et al. Muscle pathology in 57 patients with myotonic dystrophy type 2. Muscle Nerve 2004, 29:275-281.
35. Sermon K., Seneca S., De Rycke M. PGD in the lab for triplet repeat diseases-myotonic dystrophy. Huntington's disease and fragile-X syndrome. Mol. Cell. Endocrinol. 2001, 183:S77-S85.
36. Shaw D.J., et al. Genomic organization and transcriptional units at the myotonic dystrophy locus. Genomics 1993, 18:673-679.
37. Sovari A.A., Bodine C.K., Farokhi F. Cardiovascular manifestations of myotonic dystrophy-1. Cardiology 2007, 15(4):191-194.
38. Sugino M., et al. A pilot study of dehydroepiandrosterone sulfate in myotonic dystrophy. Neurology 1998, 51:586-589.
39. Timchenko N.A., Cai Z.-J., Welm A.L., Reddy S., Ashizawa T., Timchenko L.T. RNA CUG repeats sequester and alter protein levels and activity of CUGBP1. J. Biol. Chem. 2001, 276:7820-7826.
40. Tishkoff D., Filosi N., Gaida G., Kolodner R. A novel mutation avoidance mechanism dependent on S. cerevisiae RAD27 is distinct from DNA mismatch repair. Cell 1997, 88:253-263.
41. Trip J., et al. Drug treatment for myotonia. Cochrane Database Syst. Rev. 2007, 4:CD004762.
42. Warner J.P., et al. A general method for the detection of large CAG repeat expansions by fluorescent PCR. J. Med. Genet. 1996, 33:1022-1026.
43. Wheeler T.M., et al. Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. J. Clin. Invest. 2007, 117:3952-3957.
44. Wintzen A.R., Lammers G.J., van Dijk J.G. Does modafinil enhance activity of patients with myotonic dystrophy? A double-blind placebo-controlled crossover study. J. Neurol. 2007, 254:26-28.